Alterity Therapeutics Limited Share Price Nasdaq
Stocks
ATHE
US02155X2053
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
01:30:00 11/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 4.110 USD | -8.67% |
|
-9.07% | +33.44% |
| Market Cap | 7.52Cr 6.47Cr 6.1Cr 5.56Cr 10Cr 719.12Cr 10Cr 73Cr 28Cr 364.75Cr 28Cr 28Cr 1.16TCr | P/E 2027 * |
-4.8x | P/E 2028 * | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | 3.43Cr 2.95Cr 2.78Cr 2.54Cr 4.74Cr 328.06Cr 4.78Cr 33Cr 13Cr 166.4Cr 13Cr 13Cr 528.53Cr | EV / Sales 2027 * |
60.1x | EV / Sales 2028 * | 16.5x |
| Free-Float |
93.14% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ATHE | Delayed | |
Deutsche Boerse AG
| PBN0 | Delayed | |
|
CBOE
| ATHE | Real-time | |
|
Börse Stuttgart
| PBN0 | Delayed |
Last Transcript : Alterity Therapeutics Limited
| 1 day | -8.67% | ||
| 1 week | -9.07% | ||
| Current month | -8.46% | ||
| 1 month | -9.57% | ||
| 3 months | -0.96% | ||
| 6 months | +13.54% | ||
| Current year | +33.44% |
| 1 week | 4.11 |  | 4.64 |
| 1 month | 4.11 | | 5.04 |
| Current year | 3.02 | | 5.89 |
| 1 year | 2.66 | | 5.89 |
| 3 years | 1 | | 7 |
| 5 years | 1 | | 13.9 |
| 10 years | 1 | | 53.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 07/01/2021 |
| Director of Finance/CFO | - | 30/09/2024 | |
| Chief Tech/Sci/R&D Officer | - | 01/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 29/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 08/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 21/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.67% | -9.07% | - | - | 7.52Cr | |
| -0.56% | -8.08% | -3.88% | +10.58% | 4.61TCr | |
| -2.08% | -3.57% | +402.72% | +533.09% | 4.36TCr | |
| +0.12% | -5.27% | +39.94% | +20.50% | 4.24TCr | |
| -2.62% | -5.76% | +8.88% | +77.44% | 3.89TCr | |
| -1.26% | -3.37% | +11.87% | +40.55% | 3.22TCr | |
| +0.16% | -3.65% | - | - | 1.72TCr | |
| -0.54% | -1.72% | +22.34% | +115.10% | 1.63TCr | |
| -0.03% | -3.46% | +12.68% | +30.90% | 1.43TCr | |
| -1.92% | -6.94% | +78.12% | +36.68% | 1.3TCr | |
| Average | -1.74% | -4.70% | +71.58% | +108.10% | 2.93TCr | |
| Weighted average by Cap. | -1.08% | -5.04% | +86.56% | +128.49% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 6L 5L 5L 4L 8L 5.45Cr 8L 55.13L 21.22L 2.77Cr 21.42L 20.96L 8.79Cr | 23.08L 19.85L 18.73L 17.06L 31.89L 22Cr 32.18L 2.23Cr 85.84L 11Cr 86.67L 84.78L 36Cr |
| Net income | -2.68Cr -2.31Cr -2.18Cr -1.98Cr -3.7Cr -256.31Cr -3.74Cr -26Cr -9.97Cr -130Cr -10Cr -9.85Cr -412.93Cr | -2.98Cr -2.56Cr -2.42Cr -2.2Cr -4.12Cr -284.85Cr -4.15Cr -29Cr -11Cr -144.48Cr -11Cr -11Cr -458.91Cr |
| Net Debt | -4.09Cr -3.52Cr -3.32Cr -3.02Cr -5.65Cr -391.06Cr -5.7Cr -40Cr -15Cr -198.35Cr -15Cr -15Cr -630.01Cr | -3.72Cr -3.2Cr -3.01Cr -2.75Cr -5.13Cr -355.2Cr -5.18Cr -36Cr -14Cr -180.16Cr -14Cr -14Cr -572.25Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $4.110 | -8.67% | 56,867 |
| 09/26/09 | $4.500 | -0.22% | 18,874 |
| 08/26/08 | $4.510 | -0.66% | 16,172 |
| 04/26/04 | $4.540 | +0.44% | 4,563 |
| 03/26/03 | $4.520 | 0.00% | 13,255 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
- ATHE Stock
Select your edition
All financial news and data tailored to specific country editions
